What is Huntington's Disease?

Huntington's disease (HD), also known historically as Huntington's chorea, is a progressive brain disorder caused by a defective gene on chromosome 4. It results in the gradual breakdown of nerve cells in the brain, leading to impairments in movement, cognition, and psychiatric health. The term "chorea" refers to the characteristic jerky, involuntary movements often seen in affected individuals.

Key Symptoms and Features

Symptoms typically appear between the ages of 30 and 50, but can start earlier (juvenile-onset) or later in life. Common signs include:

• Chorea: Involuntary writhing or jerking movements of the limbs, face, and trunk.
• Cognitive decline: Difficulty with executive function, memory loss, and poor judgment.
• Psychiatric disturbances: Depression, anxiety, irritability, and sometimes obsessive-compulsive behavior.
• Speech and swallowing problems: Dysarthria and dysphagia develop as the disease progresses.

Genetic Basis and Inheritance

Huntington's chorea is an autosomal dominant disorder, meaning a child of an affected parent has a 50% chance of inheriting the mutation. The defect involves an expanded CAG trinucleotide repeat in the huntingtin (HTT) gene. The longer the repeat, the earlier and more severe the symptoms often become—this is known as anticipation. Genetic testing can confirm the diagnosis and identify at-risk individuals before symptoms appear.

Treatment and Management

There is currently no cure for Huntington's chorea. Treatment focuses on managing symptoms and improving quality of life:

• Medications: Tetrabenazine and deutetrabenazine can help control chorea. Antipsychotics and antidepressants address psychiatric symptoms.
• Therapies: Physical therapy improves mobility and balance; speech therapy aids communication; occupational therapy helps maintain daily function.
• Supportive care: Multidisciplinary teams including neurologists, genetic counselors, and social workers provide comprehensive management.

Current Research and Future Directions

Researchers are investigating potential disease-modifying therapies, including gene silencing (using antisense oligonucleotides to reduce mutant huntingtin production) and stem cell transplantation. Clinical trials continue to explore agents that might slow disease progression. Early detection through genetic and biomarker screening remains a critical area of study.

Living with Huntington's Chorea

For individuals and families affected by this condition, support groups and counseling are invaluable. Organizations such as the Huntington's Disease Society of America offer resources, advocacy, and community connections. With advancing research, there is hope for future breakthroughs that may alter the course of this devastating disease.